ARPA-H Launches Agentic AI Cardiovascular Program

The U.S. ARPA-H is soliciting proposals for ADVOCATE, a multiyear program to develop FDA-authorized agentic AI systems for cardiovascular care, expecting teams to deliver two agents and seek authorization within roughly three years, with a proposal-summary deadline of Feb. 27. Simultaneously, CMS is advancing interoperability standards and the FDA cleared Aidoc’s AI triage detecting 14 acute CT conditions, highlighting regulatory alignment.